Intraperitoneal administration of cisplatin plus bevacizumab for the management of malignant ascites in ovarian epithelial cancer: results of a phase III clinical trial.

Zhao, Hui; Li, Xiaosong; Chen, Dianjun; Cai, Jianhua; Fu, Yan; Kang, Huanrong; Gao, Jie; Gao, Ke; Du, Nan

Zhao, Hui; Li, Xiaosong; Chen, Dianjun; Cai, Jianhua; Fu, Yan; Kang, Huanrong; Gao, Jie; Gao, Ke; Du, Nan.

Affiliation

Zhao H; Department of Oncology, First Affiliated Hospital of Chinese PLA General Hospital, Beijing, 100037, China.

Med Oncol ; 32(2): 292, 2015 Feb.

Article in En | MEDLINE | ID: mdl-25609006

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/administration & dosage; Ascites/drug therapy; Neoplasms, Glandular and Epithelial/drug therapy; Ovarian Neoplasms/drug therapy; Aged; Antibodies, Monoclonal, Humanized/administration & dosage; Antibodies, Monoclonal, Humanized/adverse effects; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Ascites/etiology; Bevacizumab; CA-125 Antigen/analysis; Carcinoma, Ovarian Epithelial; Cisplatin/administration & dosage; Cisplatin/adverse effects; Enzyme-Linked Immunosorbent Assay; Female; Humans; Injections, Intraperitoneal; Middle Aged; Neoplasms, Glandular and Epithelial/complications; Ovarian Neoplasms/complications; Quality of Life; Vascular Endothelial Growth Factor A/analysis

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Ascites / Antineoplastic Combined Chemotherapy Protocols / Neoplasms, Glandular and Epithelial Type of study: Clinical_trials / Etiology_studies Aspects: Patient_preference Limits: Aged / Female / Humans / Middle aged Language: En Journal: Med Oncol Journal subject: NEOPLASIAS Year: 2015 Document type: Article Affiliation country: China

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google